ES2570758T3 - Materiales y métodos para el control de enfermedades respiratorias en cánidos - Google Patents

Materiales y métodos para el control de enfermedades respiratorias en cánidos

Info

Publication number
ES2570758T3
ES2570758T3 ES06769869T ES06769869T ES2570758T3 ES 2570758 T3 ES2570758 T3 ES 2570758T3 ES 06769869 T ES06769869 T ES 06769869T ES 06769869 T ES06769869 T ES 06769869T ES 2570758 T3 ES2570758 T3 ES 2570758T3
Authority
ES
Spain
Prior art keywords
amino acid
canids
materials
methods
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06769869T
Other languages
English (en)
Spanish (es)
Inventor
Patti C Crawford
Paul J Gibbs
Edward J Dubovi
Ruben O Donis
Jacqueline Katz
Alexander I Klimov
William L Castleman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
University of Florida
University of Florida Research Foundation Inc
US Department of Health and Human Services
Original Assignee
Cornell Research Foundation Inc
University of Florida
University of Florida Research Foundation Inc
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc, University of Florida, University of Florida Research Foundation Inc, US Department of Health and Human Services filed Critical Cornell Research Foundation Inc
Application granted granted Critical
Publication of ES2570758T3 publication Critical patent/ES2570758T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES06769869T 2005-04-21 2006-04-21 Materiales y métodos para el control de enfermedades respiratorias en cánidos Expired - Lifetime ES2570758T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67344305P 2005-04-21 2005-04-21
PCT/US2006/015090 WO2006116082A1 (en) 2005-04-21 2006-04-21 Materials and methods for respiratory disease control in canines

Publications (1)

Publication Number Publication Date
ES2570758T3 true ES2570758T3 (es) 2016-05-20

Family

ID=37215064

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06769869T Expired - Lifetime ES2570758T3 (es) 2005-04-21 2006-04-21 Materiales y métodos para el control de enfermedades respiratorias en cánidos

Country Status (16)

Country Link
EP (3) EP2489739B1 (enExample)
JP (6) JP2008536526A (enExample)
KR (3) KR101738940B1 (enExample)
CN (3) CN103451158B (enExample)
AU (1) AU2006240038B2 (enExample)
BR (2) BR122018012345B1 (enExample)
CA (1) CA2606429A1 (enExample)
ES (1) ES2570758T3 (enExample)
IL (3) IL186710A (enExample)
MX (3) MX358750B (enExample)
NO (2) NO345667B1 (enExample)
NZ (2) NZ583564A (enExample)
RU (2) RU2449014C2 (enExample)
SG (2) SG10201406043TA (enExample)
WO (1) WO2006116082A1 (enExample)
ZA (1) ZA200708897B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
EP2489739B1 (en) * 2005-04-21 2019-11-20 University of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
EP2471805A3 (en) 2005-05-06 2013-01-16 Gen-Probe Incorporated Compositions and assays to specifically detect nucleic acid of influenza virus A or B
US7425336B2 (en) * 2005-08-25 2008-09-16 Mevial Limited Canine influenza vaccines
NZ566490A (en) 2005-10-07 2011-06-30 Pfizer Prod Inc Live attenuated or killed H3N8 influenza vaccines and methods to treat canine influenza
US7468187B2 (en) 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
AU2006304747B2 (en) * 2005-10-19 2013-10-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
AU2013205112C1 (en) * 2005-10-19 2015-12-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
WO2007047728A2 (en) * 2005-10-20 2007-04-26 Wyeth Compositions and methods for the treatment of canine influenza virus disease
GB0613977D0 (en) 2006-02-07 2006-08-23 Peptcell Ltd Peptide sequences and compositions
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US7674469B2 (en) 2006-10-25 2010-03-09 Internet International B.V. Feline influenza vaccine and method of use
CN101838708B (zh) * 2010-03-30 2012-07-18 华南农业大学 一种检测犬流感的方法
CA2898633C (en) * 2013-02-07 2021-07-13 Massachusetts Institute Of Technology Human adaptation of h5 influenza
CN103881983B (zh) * 2014-03-07 2016-08-31 中国农业科学院哈尔滨兽医研究所 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗
WO2017004453A1 (en) * 2015-07-02 2017-01-05 Indevr, Inc. Universal priming mixture for amplification of influenza viral gene segments for diagnostic applications
MX2021014912A (es) * 2019-06-07 2022-01-18 Intervet Int Bv Celula mutante mdbk con inactivacion de irf3/irf7 y su uso para producir vacunas.
CN110592276A (zh) * 2019-07-08 2019-12-20 北京世纪元亨动物防疫技术有限公司 用于检测犬流感病毒的特异性引物及试剂盒
CN115074461B (zh) * 2021-03-11 2023-08-25 上海市农业科学院 犬流感病毒、犬冠状病毒和犬呼肠孤病毒的三重pcr检测方法
CN115725517B (zh) * 2022-09-01 2026-01-02 军事科学院军事医学研究院军事兽医研究所 一种h3n2犬流感重组病毒株及其应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034322A (en) 1983-01-17 1991-07-23 Monsanto Company Chimeric genes suitable for expression in plant cells
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5106739A (en) 1989-04-18 1992-04-21 Calgene, Inc. CaMv 355 enhanced mannopine synthase promoter and method for using same
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US5612487A (en) 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US5484719A (en) 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
UA48104C2 (uk) 1991-10-04 2002-08-15 Новартіс Аг Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника
RU2193065C2 (ru) * 1994-03-14 2002-11-20 Мерк энд Ко. Инк. Конструкция днк (варианты), днк-вектор, иммуногенная композиция против вируса гриппа, способ индукции иммунного ответа, вакцина и способ вакцинации
ES2293639T3 (es) * 1994-03-30 2008-03-16 Connaught Technology Corporation Secuencias de nucleotidos y aminoacidos de los virus gb, gc y gd del herpes canino y sus usos.
GB9524395D0 (en) 1995-11-29 1996-01-31 Nickerson Biocem Ltd Promoters
US6252139B1 (en) 1996-07-18 2001-06-26 The Salk Institute For Biological Studies Method of increasing growth and yield in plants
US6063385A (en) 1997-11-07 2000-05-16 Wisconsin Alumni Research Foundation DNA vaccine for parvovirus
US6472375B1 (en) 1998-04-16 2002-10-29 John Wayne Cancer Institute DNA vaccine and methods for its use
US6579528B1 (en) * 1998-08-13 2003-06-17 The University Of Pittsburgh - Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6177082B1 (en) * 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6482414B1 (en) * 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
AU762798B2 (en) 1998-11-24 2003-07-03 Pioneer Hi-Bred International, Inc. Root-preferred promoters and their use
JP2000230931A (ja) * 1998-12-07 2000-08-22 Katakura Industries Co Ltd 家畜インフルエンザウイルスに対する抗体の検出方法およびこれに用いるキット
DE19960843A1 (de) 1999-12-16 2001-06-28 Florian Grundler Wurzelspezifischer Promotor
PL205955B1 (pl) * 2000-04-28 2010-06-30 St Jude Childrens Res Hospital Układ oparty na minimalnej liczbie plazmidów do wytwarzania infekcyjnych wirusów RNA o ujemnej nici, komórka gospodarza zawierająca taki układ, sposób wytwarzania wiriona wirusa RNA o ujemnej nici, sposób wytwarzania atenuowanego wirusa RNA o ujemnej nici, sposób wytwarzania zakaźnego wirusa o ujemnej nici do stosowania w szczepionkach i zastosowanie układu opartego na minimalnej liczbie plazmidów
EP1292614A2 (en) * 2000-06-23 2003-03-19 American Cyanamid Company Nucleotide sequence of influenza a/udorn/72 (h3n2) genome
US6455760B1 (en) 2000-11-16 2002-09-24 The Salk Institute Of Biological Studies Expression of flavin-containing monoxygenases in plants
US20040067506A1 (en) 2000-12-04 2004-04-08 Ben Scheres Novel root specific promoter driving the expression of a novel lrr receptor-like kinase
JP2005538343A (ja) * 2002-04-12 2005-12-15 イラリア・カプア ノイラミニダーゼをコードする精製サブフラグメント、組み換えノイラミニダーゼ、及び動物予防におけるその使用
US7285656B2 (en) 2002-04-26 2007-10-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Natural Resources Canada, Canadian Forest Service Root-specific conifer gene promoter and its use
JP2006512906A (ja) * 2002-09-28 2006-04-20 マサチューセッツ インスティチュート オブ テクノロジー インフルエンザ治療剤
AU2003294533A1 (en) * 2002-12-19 2004-07-14 Universite Laval Molecular methods and compositions for detecting and quantifying respiratory viruses
US20040123349A1 (en) 2002-12-20 2004-06-24 Qi Xie SINAT5, an Arabidopsis thaliana gene promotes ubiquitin related degradation
NZ543196A (en) * 2003-05-15 2008-04-30 Univ Oklahoma State DNA vaccine expressing HA1 but not HA2 of equine-2 influenza virus
CN1458168A (zh) * 2003-06-02 2003-11-26 中国农业科学院哈尔滨兽医研究所 重组猪流感病毒np抗原、其制备方法及在诊断中的应用
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
EP2489739B1 (en) * 2005-04-21 2019-11-20 University of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
NZ566490A (en) * 2005-10-07 2011-06-30 Pfizer Prod Inc Live attenuated or killed H3N8 influenza vaccines and methods to treat canine influenza
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
AU2006304747B2 (en) * 2005-10-19 2013-10-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
WO2007047728A2 (en) * 2005-10-20 2007-04-26 Wyeth Compositions and methods for the treatment of canine influenza virus disease
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus

Also Published As

Publication number Publication date
EP2495326B1 (en) 2019-11-20
MX339202B (es) 2016-05-13
JP6301855B2 (ja) 2018-03-28
JP2013031440A (ja) 2013-02-14
JP2024043541A (ja) 2024-03-29
JP2020031658A (ja) 2020-03-05
WO2006116082A1 (en) 2006-11-02
NZ562661A (en) 2010-04-30
KR101738937B1 (ko) 2017-05-23
IL208707A0 (en) 2010-12-30
RU2007143041A (ru) 2009-05-27
EP2489739B1 (en) 2019-11-20
CN101253267A (zh) 2008-08-27
BRPI0610503B1 (pt) 2022-05-31
JP6663416B2 (ja) 2020-03-11
CN107099512A (zh) 2017-08-29
NO345667B1 (no) 2021-06-07
IL249236B (en) 2021-07-29
RU2711791C2 (ru) 2020-01-22
MX2018010571A (es) 2022-01-25
IL249236A0 (en) 2017-01-31
KR20150082628A (ko) 2015-07-15
IL186710A (en) 2017-09-28
EP1871885A4 (en) 2009-09-16
KR20080039836A (ko) 2008-05-07
MX358750B (es) 2018-08-31
KR20140091770A (ko) 2014-07-22
KR101738940B1 (ko) 2017-06-08
NZ583564A (en) 2011-09-30
RU2020100038A (ru) 2021-07-09
SG10201910006WA (en) 2019-11-28
NO342494B1 (no) 2018-06-04
NO20180601A1 (no) 2008-01-21
JP2018050636A (ja) 2018-04-05
AU2006240038B2 (en) 2012-07-05
CA2606429A1 (en) 2006-11-02
EP1871885B1 (en) 2016-02-17
EP2495326A2 (en) 2012-09-05
JP2015144604A (ja) 2015-08-13
AU2006240038A1 (en) 2006-11-02
EP1871885B8 (en) 2017-08-02
EP1871885A1 (en) 2008-01-02
EP2489739A2 (en) 2012-08-22
BR122018012345B1 (pt) 2021-10-26
IL208707B (en) 2020-01-30
IL186710A0 (en) 2008-02-09
KR101474011B1 (ko) 2014-12-23
JP2008536526A (ja) 2008-09-11
RU2011153597A (ru) 2013-07-10
EP2495326A3 (en) 2013-08-28
SG10201406043TA (en) 2014-11-27
EP2489739A3 (en) 2013-08-28
CN103451158B (zh) 2018-11-23
NO20075961L (no) 2008-01-21
RU2449014C2 (ru) 2012-04-27
CN103451158A (zh) 2013-12-18
JP6042131B2 (ja) 2016-12-14
ZA200708897B (en) 2009-01-28
HK1111729A1 (zh) 2008-08-15
BRPI0610503A2 (pt) 2010-06-29

Similar Documents

Publication Publication Date Title
ES2691539T3 (es) Luciferasas de Oplophorus sintéticas con mayor emisión de luz
ECSP19034870A (es) Péptidos escindibles y proteínas insecticidas y nematicidas que los comprenden
ES2616658T3 (es) Péptidos que mimetizan el factor de crecimiento y sus usos
CU20220029A7 (es) Receptores de tcr de prame
NZ595736A (en) Chimeric viruses presenting non-native surface proteins and uses thereof
EA201592306A1 (ru) Вакцины против вируса гриппа и их применения
ES2534744T3 (es) Plasmina modificada de forma recombinante
AR067980A1 (es) Peptidos de cdh3 y agentes que los comprenden
HRP20220980T1 (hr) Cjepiva protiv virusa influence i njihova uporaba
CL2017000200A1 (es) Célula huésped mejorada para producir proteinas
BR112016026842A2 (pt) preparação compreendendo fator viii e peptídeos de fator de von willebrand
EA200901441A1 (ru) Новые молекулы антител и нуклеиновых кислот, связывающиеся с грибным белком теплового шока hsp90
PE20120400A1 (es) Contrucciones de casb7439
CL2020002373A1 (es) Composición de vacuna que comprende un péptido aislado de piojo de mar; uso de la vacuna para para prevenir o controlar una infestación de piojos de mar en un salmónido; vector; célula hospedadora (divisional de la solicitud no. 201900422).
BR112022006578A2 (pt) Polipeptídeos de fusão e de hemaglutinina do vírus da cinomose canina
AR056133A1 (es) Virus de influenza canina y composiciones relacionadas y metodos de uso
MX2021012991A (es) Antigenos de gripe recombinantes.
DE60236579D1 (de) Bakteriophagenvermittelte impfung
ES2557938T3 (es) Antagonistas de resistina y su uso
PH12022553417A1 (en) Stabilized corona virus spike protein fusion proteins
MX2019002134A (es) Nuevo paramixovirus y sus usos.
CO6311116A2 (es) Sistema para la expresion de peptidos sobre la superficie bacteriana de escherichia coli
ES2531098T3 (es) Nuevos mutantes de proteína de superficie del antígeno de superficie del virus HVB de Hepatitis B (HBsAg)
NO20085201L (no) Rekombinante novirhabdoviruser og deres anvendelse
JP2016525535A5 (enExample)